A detailed history of Edmond De Rothschild Holding S.A. transactions in Dexcom Inc stock. As of the latest transaction made, Edmond De Rothschild Holding S.A. holds 4,115 shares of DXCM stock, worth $320,147. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,115
Previous 2,135 92.74%
Holding current value
$320,147
Previous $242,000 13.64%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$64.0 - $116.06 $126,720 - $229,798
1,980 Added 92.74%
4,115 $275,000
Q2 2024

Aug 13, 2024

SELL
$110.31 - $140.45 $110,310 - $140,450
-1,000 Reduced 31.9%
2,135 $242,000
Q1 2024

May 08, 2024

BUY
$114.22 - $140.1 $119,931 - $147,105
1,050 Added 50.36%
3,135 $434,000
Q4 2023

Feb 12, 2024

SELL
$75.49 - $124.16 $859,604 - $1.41 Million
-11,387 Reduced 84.52%
2,085 $258,000
Q3 2023

Nov 13, 2023

SELL
$86.06 - $137.93 $285,719 - $457,927
-3,320 Reduced 19.77%
13,472 $1.26 Million
Q2 2023

Aug 09, 2023

BUY
$112.47 - $130.98 $98,186 - $114,345
873 Added 5.48%
16,792 $2.16 Million
Q1 2023

May 11, 2023

SELL
$104.0 - $122.92 $895,336 - $1.06 Million
-8,609 Reduced 35.1%
15,919 $1.85 Million
Q4 2022

Feb 09, 2023

SELL
$84.98 - $122.67 $47,418 - $68,449
-558 Reduced 2.22%
24,528 $2.78 Million
Q3 2022

Nov 09, 2022

BUY
$76.35 - $94.18 $10,001 - $12,337
131 Added 0.52%
25,086 $2.02 Million
Q2 2022

Aug 12, 2022

BUY
$67.99 - $132.89 $1.41 Million - $2.75 Million
20,675 Added 483.06%
24,955 $1.86 Million
Q1 2022

May 10, 2022

BUY
$94.08 - $130.2 $402,662 - $557,256
4,280 New
4,280 $2.19 Million
Q4 2021

Feb 10, 2022

SELL
$129.87 - $162.82 $232,467 - $291,447
-1,790 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$106.71 - $143.18 $191,010 - $256,292
1,790 New
1,790 $979,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Edmond De Rothschild Holding S.A. Portfolio

Follow Edmond De Rothschild Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.